Patents as proxies: NIH hubs of innovation

被引:11
作者
Kalutkiewicz, Michael J. [1 ]
Ehman, Richard L. [2 ]
机构
[1] Acad Radiol Res, Washington, DC 20036 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN USA
关键词
CITATIONS;
D O I
10.1038/nbt.2917
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:536 / 538
页数:3
相关论文
共 11 条
[1]  
[Anonymous], 2012, NAT BIOEC BLUEPR
[2]  
Ehrlich E., 2012, NIHS ROLE SUSTAINING
[3]  
Families USA's Global Health Initiative, 2008, YOUR OWN BACKY NIH F
[4]  
Hall B.H., 2007, ACAD MANAGEMENT P, V2007, P1, DOI 10.5465/ambpp.2007.26530853
[5]  
Hall BH, 2005, RAND J ECON, V36, P16
[6]   Determinants of opposition against EPO patent grants - The case of biotechnology and pharmaceuticals [J].
Harhoff, D ;
Reitzig, M .
INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION, 2004, 22 (04) :443-480
[7]  
Harhoff D., 1997, 49726 FS WISS
[8]  
Rothwell J., 2013, PATENTING PROSPERITY
[9]   Double trouble? To throw cash at science is a mistake [J].
Sarewitz, Daniel .
NATURE, 2010, 468 (7321) :135-135
[10]   A PENNY FOR YOUR QUOTES - PATENT CITATIONS AND THE VALUE OF INNOVATIONS [J].
TRAJTENBERG, M .
RAND JOURNAL OF ECONOMICS, 1990, 21 (01) :172-187